Recent Advances in the Evaluation of the TAVI Candidate Alfonso Medina, MD

More articles by this author

Chronic Cerebrospinal Venous Insufficiency (CCSVI): Diagnosis and Management Marjeta Zorc, MD

Chronic Cerebrospinal Venous Insufficiency (CCSVI): Diagnosis and Management Marjeta Zorc, MD

Left Atrial Appendage Closure: Still under fire? Mayra Guerrero, MD

Left Atrial Appendage Closure: Still under fire? Mayra Guerrero, MD

Bleeding Risk Estimation and the New (BARC) Definition of Bleeding Events Dr. Franz Weidinger

Bleeding Risk Estimation and the New (BARC) Definition of Bleeding Events Dr. Franz Weidinger

Which Antiplatelet Therapy for Which Patient? Dr. Thomas Cuisset

Which Antiplatelet Therapy for Which Patient? Dr. Thomas Cuisset

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...

Inflammation after TAVI: An Emerging Therapeutic Target?

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...